Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve Approval of Financial statement for the year ended March 31, 2024

pdf

Dr. Lalchandani Labs Ltd.

02 May 2024

23.90

3.87%

Company Update

Dr Lalchandani Labs Ltd - 541299 - Appointment of Company Secretary and Compliance Officer

BSE India

Appointment of Ms. Namita Anand as Company Secretary and Compliance officer of the Company

pdf

Dr. Lalchandani Labs Ltd.

20 Apr 2024

23.90

3.87%

Company Update

Dr Lalchandani Labs Ltd - 541299 - Compliance Certificate Under Regulation 40(10) Of SEBI (LODR) Regulations, …

BSE India

compliance certificate under Reg 40(10) for the quarter ended March 2024

pdf

Dr. Lalchandani Labs Ltd.

17 Apr 2024

23.90

3.87%

Company Update

Dr Lalchandani Labs Ltd - 541299 - Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations …

BSE India

Compliance Certificate for the year ended March 2024

pdf

Dr. Lalchandani Labs Ltd.

15 Apr 2024

23.90

3.87%

Company Update

Dr Lalchandani Labs Ltd - 541299 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Certificate by RTA under Reg 74(5) for the quarter ended March, 2024

pdf

Dr. Lalchandani Labs Ltd.

10 Apr 2024

23.90

3.87%

Company Update

Dr Lalchandani Labs Ltd - 541299 - Reply To The Clarification Sought Dated April 09, 2024

BSE India

Reply to the clarification sought

pdf

Dr. Lalchandani Labs Ltd.

09 Apr 2024

23.90

3.87%

Company Update

Dr Lalchandani Labs Ltd - 541299 - Clarification sought from Dr Lalchandani Labs Ltd

BSE India

The Exchange has sought clarification from Dr Lalchandani Labs Ltd on April 09, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.

Dr. Lalchandani Labs Ltd.

09 Apr 2024

23.90

3.87%

Corp. Note

Dr Lalchandani Labs Ltd - 541299 - Format of the Annual Disclosure to be made by …

BSE India

Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Dr Lalchandani Labs Ltd 2 CIN NO. L85320DL2017PLC321605 3 Report filed for FY 2023-2024 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* 2023-2024 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) 0 8Quantum of (d), which has been met from (c)(e)* 0 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* 0 Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)2023-2024 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-NoneDesignation :-None Name of the Chief Financial Officer :- Anchal Gupta Designation : -Chief Financial Officer Date: 09/04/2024

pdf

VOTE: Is Dr. Lalchandani Labs Ltd. worth buying?

3 Votes:

Buy 33.33%

Sell 66.67%